EUVIMEDEUVIMED entdecken
Netzwerk-Metaanalyse

Thermal Ablation Modalities That Best Compete with Partial Nephrectomy for T1A and T1B Renal Cell Carcinoma: A Network Meta-Analysis

Mahmoud Shaaban Abdelgalil, Alina Ghazou, Mohamed A Aldemerdash, Mohamed Abdelaal Nasser, Hajer Bassem, Ahmad Abdelrazek, Asmaa Elganady, Mohamed Mansour, Ahmed K Awad, Omar Saeed, Ayman K Awad, Mohamed Abd-ElGawad

Journal of Vascular and Interventional Radiology · 2025-10 · 36 (10) · 1475-1491.e53

DOI: 10.1016/j.jvir.2025.05.032 ↗

Kurz gefasst

Netzwerk-Metaanalyse in der Zeitschrift Journal of Vascular and Interventional Radiology, 2025-10. Verfasst von Mahmoud Shaaban Abdelgalil und 11 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Ain Shams University, Cairo, Egypt. Electronic address: 29908068800596@med.asu.edu.eg. Hauptthemen laut MEDLINE: Ablation Techniques, Carcinoma, Renal Cell, Cryosurgery, Kidney Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 94 Literaturangaben. Gefördert von: University of Texas MD Anderson Cancer Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To address the lack of consensus on the ranking of thermal ablation (TA) for treating T1A and T1B renal cell carcinoma (RCC), a network meta-analysis was conducted to compare the efficacy and safety of different TA modalities for managing early-stage RCC. METHODS: The Cochrane Library, PubMed, Scopus, and Web of Science were systematically searched for studies comparing percutaneous and laparoscopic radiofrequency ablation (RFA), cryoablation (CRA), and microwave ablation (MWA) with open, laparoscopic, and robotic partial nephrectomy (PN) for T1A and T1B RCC. Primary outcomes were recurrence-free survival (RFS), local recurrence, and postprocedural adverse events. Secondary outcomes included overall survival, cancer-specific mortality, changes in estimated glomerular filtration rate, hospital stay length, major adverse events, operation time, and systemic recurrence. RESULTS: Thirty-two studies were included, comprising 8,568 patients in T1A studies and 1,019 in T1B studies. For T1A tumors, no significant differences in 5-year RFS were observed between open PN and percutaneous RFA (P = .655), percutaneous CRA (P = .369), laparoscopic RFA (P = 1.000), or laparoscopic CRA (P = .547). However, percutaneous MWA reduced local recurrence (P = .033) and had lower postprocedural adverse events compared with PN (P = .029). For T1B tumors, no significant differences in 5-year RFS, local recurrence, or postprocedural adverse events were observed between open PN and percutaneous RFA or percutaneous CRA. CONCLUSION: Although data gaps exist, percutaneous TA demonstrated outcomes comparable with surgery for both T1A and T1B renal tumors. For T1A tumors, percutaneous MWA may be highly effective. For T1B tumors, the similar outcomes across percutaneous approaches support tailoring treatment based on patient factors and operator expertise.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ablation TechniquesCarcinoma, Renal CellCryosurgeryKidney NeoplasmsLaparoscopyNephrectomyRobotic Surgical ProceduresAgedFemaleHumansMaleMiddle AgedMicrowavesNeoplasm Recurrence, LocalNeoplasm StagingPostoperative ComplicationsRisk AssessmentRisk FactorsTime FactorsTreatment Outcome

Autor:innen und Institutionen

  • Faculty of Medicine, Ain Shams University, Cairo, Egypt. Electronic address: 29908068800596@med.asu.edu.eg.
  • Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.
  • Faculty of Medicine, Sohag University, Sohag, Egypt.
  • Faculty of Medicine, October 6th University, Cairo, Egypt.
  • Faculty of Medicine, Minya University, Minya, Egypt.
  • Radiology Department, Mayo Clinic, Rochester, Minnesota.

Förderung

  • University of Texas MD Anderson Cancer Center

Zitieren

APA

Shaaban Abdelgalil, M., Ghazou, A., Aldemerdash, M. A., Nasser, M. A., Bassem, H., Abdelrazek, A., Elganady, A., Mansour, M., Awad, A. K., Saeed, O., Awad, A. K., & Abd-ElGawad, M. (2025). Thermal Ablation Modalities That Best Compete with Partial Nephrectomy for T1A and T1B Renal Cell Carcinoma: A Network Meta-Analysis. Journal of Vascular and Interventional Radiology, 36(10), 1475-1491.e53. https://doi.org/10.1016/j.jvir.2025.05.032

Vancouver

Shaaban Abdelgalil M, Ghazou A, Aldemerdash MA, Nasser MA, Bassem H, Abdelrazek A, et al. Thermal Ablation Modalities That Best Compete with Partial Nephrectomy for T1A and T1B Renal Cell Carcinoma: A Network Meta-Analysis. Journal of Vascular and Interventional Radiology. 2025;36(10):1475-1491.e53. doi:10.1016/j.jvir.2025.05.032

BibTeX
@article{ShaabanAbdelgalil2025,
  author = {Shaaban Abdelgalil, Mahmoud and Ghazou, Alina and Aldemerdash, Mohamed A and Nasser, Mohamed Abdelaal and Bassem, Hajer and Abdelrazek, Ahmad and Elganady, Asmaa and Mansour, Mohamed and Awad, Ahmed K and Saeed, Omar and Awad, Ayman K and Abd-ElGawad, Mohamed},
  title = {Thermal Ablation Modalities That Best Compete with Partial Nephrectomy for T1A and T1B Renal Cell Carcinoma: A Network Meta-Analysis},
  journal = {Journal of Vascular and Interventional Radiology},
  year = {2025},
  volume = {36},
  number = {10},
  pages = {1475--1491.e53},
  doi = {10.1016/j.jvir.2025.05.032}
}
Kostenlos starten →